Status: open

Pfizer (EpiPen)

Defendant: Pfizer

Consumers who paid for branded or authorized generic EpiPens between August 24, 2011 and November 1, 2020 may be eligible for cash payment. The company reached a settlement over allegations of antitrust violations. 

Claim Deadline: Friday, 12 November 2021.